ASX Announcement 28 October 2026 Avecho Quarterly Activities Report and Appendix 4C Key Highlights ? Recruitment and dosing recommenced for the final stage of the pivotal Phase III insomnia trial, following the positive interim analysis announced in June. ? Approximately 320 additional participants...